Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 292

    1.

    Lack of Bactericidal Antagonism or Synergism In Vitro Between Oxacillin and Vancomycin Against Methicillin-Susceptible Strains of Staphylococcus Aureus.

    Joukhadar C, Pillai S, Wennersten C, Moellering RC Jr, Eliopoulos GM.

    Antimicrob Agents Chemother. 2009 Nov 23. [Epub ahead of print]PMID: 19933805 [PubMed - as supplied by publisher]

    2.

    Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists.

    Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC Jr, Craig WA, Billeter M, Dalovisio JR, Levine DP.

    Pharmacotherapy. 2009 Nov;29(11):1275-9.PMID: 19873687 [PubMed - in process]Related articles

    3.

    Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.

    Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW.

    Clin Infect Dis. 2009 Oct 15;49(8):1169-74.PMID: 19769538 [PubMed - indexed for MEDLINE]Related articles

    4.

    New treatments for multiply drug-resistant Gram-positive bacteria.

    Moellering RC Jr.

    J Infect. 2009 Sep;59 Suppl 1:S1-3. No abstract available. PMID: 19766884 [PubMed - indexed for MEDLINE]Related articles

    5.

    What is inadequate antibacterial therapy?

    Moellering RC Jr.

    Clin Infect Dis. 2009 Oct 1;49(7):1006-8. No abstract available. PMID: 19719418 [PubMed - indexed for MEDLINE]Related articles

    6.

    Competition of hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus strains in hospitals.

    Webb GF, Horn MA, D'Agata EM, Moellering RC, Ruan S.

    J Biol Dyn. 2009 Feb 1;48:271-284.PMID: 19587839 [PubMed]Related articlesFree article

    7.

    Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

    Rybak MJ, Lomaestro BM, Rotscahfer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP.

    Clin Infect Dis. 2009 Aug 1;49(3):325-7.PMID: 19569969 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.

    Naber CK, Baddour LM, Giamarellos-Bourboulis EJ, Gould IM, Herrmann M, Hoen B, Karchmer AW, Kobayashi Y, Kozlov RS, Lew D, Miró JM, Moellering RC Jr, Moreillon P, Peters G, Rubinstein E, Seifert H, Corey GR.

    Clin Infect Dis. 2009 May 15;48 Suppl 4:S260-70.PMID: 19374582 [PubMed - indexed for MEDLINE]Related articles

    9.

    Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.

    Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr, Mylonakis E.

    Antimicrob Agents Chemother. 2009 Jun;53(6):2605-9. Epub 2009 Mar 30.PMID: 19332683 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals.

    D'Agata EM, Webb GF, Horn MA, Moellering RC Jr, Ruan S.

    Clin Infect Dis. 2009 Feb 1;48(3):274-84.PMID: 19137654 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.

    Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr, Eliopoulos GM.

    J Infect Dis. 2009 Feb 15;199(4):532-6.PMID: 19125671 [PubMed - indexed for MEDLINE]Related articles

    12.

    Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa.

    Peleg AY, Tilahun Y, Fiandaca MJ, D'Agata EM, Venkataraman L, Moellering RC Jr, Eliopoulos GM.

    J Clin Microbiol. 2009 Mar;47(3):830-2. Epub 2008 Dec 30.PMID: 19116347 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Drug interactions modulate the potential for evolution of resistance.

    Michel JB, Yeh PJ, Chait R, Moellering RC Jr, Kishony R.

    Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14918-23. Epub 2008 Sep 24.PMID: 18815368 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans.

    Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr, Mylonakis E.

    Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14585-90. Epub 2008 Sep 15.PMID: 18794525 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Clinical decisions. Management of skin and soft-tissue infection.

    Chambers HF, Moellering RC Jr, Kamitsuka P.

    N Engl J Med. 2008 Sep 4;359(10):1063-7. No abstract available. PMID: 18768953 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.

    Gqada Z, Marais B, Wasserman E, Bamford C, Orth H, Sakoulas G, Rose W, Rybak MJ, Pillai S, Alder J, Moellering RC Jr, Eliopoulos GM.

    J Clin Microbiol. 2008 Jul;46(7):2471; author reply 2471-2. No abstract available. PMID: 18614667 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.

    Sakoulas G, Moellering RC Jr.

    Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S360-7. Review.PMID: 18462091 [PubMed - indexed for MEDLINE]Related articles

    18.

    Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.

    Moellering RC Jr.

    Clin Infect Dis. 2008 Apr 1;46(7):1032-7. Review.PMID: 18444820 [PubMed - indexed for MEDLINE]Related articles

    19.

    Telithromycin and the FDA: implications for the future.

    Shlaes DM, Moellering RC.

    Lancet Infect Dis. 2008 Feb;8(2):83-5. No abstract available. PMID: 18222155 [PubMed - indexed for MEDLINE]Related articles

    20.

    A 39-year-old man with a skin infection.

    Moellering RC Jr.

    JAMA. 2008 Jan 2;299(1):79-87. Epub 2007 Dec 4.PMID: 18056894 [PubMed - indexed for MEDLINE]Related articles

    21.

    Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.

    Sakoulas G, Rose W, Rybak MJ, Pillai S, Alder J, Moellering RC Jr, Eliopoulos GM.

    J Clin Microbiol. 2008 Jan;46(1):220-4. Epub 2007 Nov 14.PMID: 18003803 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.

    Moellering RC Jr, Graybill JR, McGowan JE Jr, Corey L; American Society for Microbiology.

    Am J Infect Control. 2007 Nov;35(9):S1-23; quiz S24-6. Review.PMID: 17980231 [PubMed - indexed for MEDLINE]Related articles

    23.

    Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.

    Tsakris A, Pillai SK, Gold HS, Thauvin-Eliopoulos C, Venkataraman L, Wennersten C, Moellering RC Jr, Eliopoulos GM.

    J Antimicrob Chemother. 2007 Sep;60(3):649-51. Epub 2007 Jul 10.PMID: 17623697 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Genetic diversity among Enterococcus faecalis.

    McBride SM, Fischetti VA, Leblanc DJ, Moellering RC Jr, Gilmore MS.

    PLoS One. 2007 Jul 4;2(7):e582.PMID: 17611618 [PubMed]Related articlesFree article

    25.

    Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.

    Moellering RC Jr, Graybill JR, McGowan JE Jr, Corey L.

    Am J Med. 2007 Jul;120(7):S4-25; quiz S26-8.PMID: 17602911 [PubMed - indexed for MEDLINE]Related articles

    26.

    The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.

    Tenover FC, Moellering RC Jr.

    Clin Infect Dis. 2007 May 1;44(9):1208-15. Epub 2007 Mar 28. Review.PMID: 17407040 [PubMed - indexed for MEDLINE]Related articles

    27.

    Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.

    Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC Jr, Eliopoulos GM.

    Antimicrob Agents Chemother. 2007 Jun;51(6):2223-5. Epub 2007 Apr 2.PMID: 17404001 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.

    Sakoulas G, Alder J, Thauvin-Eliopoulos C, Moellering RC Jr, Eliopoulos GM.

    Antimicrob Agents Chemother. 2006 Apr;50(4):1581-5.PMID: 16569891 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    The growing menace of community-acquired methicillin-resistant Staphylococcus aureus.

    Moellering RC Jr.

    Ann Intern Med. 2006 Mar 7;144(5):368-70. No abstract available. PMID: 16520479 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.

    Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM.

    J Antimicrob Chemother. 2006 Apr;57(4):699-704. Epub 2006 Feb 7.PMID: 16464892 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    The management of infections due to drug-resistant gram-positive bacteria.

    Moellering RC Jr.

    Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):777-9. Review. No abstract available. PMID: 16362382 [PubMed - indexed for MEDLINE]Related articles

    32.

    Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.

    Sakoulas G, Moellering RC Jr, Eliopoulos GM.

    Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S40-50. Review.PMID: 16323119 [PubMed - indexed for MEDLINE]Related articles

    33.

    Vancomycin: a 50-year reassessment.

    Moellering RC Jr.

    Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S3-4. No abstract available. PMID: 16323117 [PubMed - indexed for MEDLINE]Related articles

    34.

    In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria.

    Eliopoulos GM, Ferraro MJ, Wennersten CB, Moellering RC Jr.

    Antimicrob Agents Chemother. 2005 Jul;49(7):3034-9.PMID: 15980394 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.

    Sakoulas G, Eliopoulos GM, Fowler VG Jr, Moellering RC Jr, Novick RP, Lucindo N, Yeaman MR, Bayer AS.

    Antimicrob Agents Chemother. 2005 Jul;49(7):2687-92.PMID: 15980337 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The importance of bactericidal drugs: future directions in infectious disease.

    Finberg RW, Moellering RC, Tally FP, Craig WA, Pankey GA, Dellinger EP, West MA, Joshi M, Linden PK, Rolston KV, Rotschafer JC, Rybak MJ.

    Clin Infect Dis. 2004 Nov 1;39(9):1314-20. Epub 2004 Oct 7. Review.PMID: 15494908 [PubMed - indexed for MEDLINE]Related articles

    37.

    Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.

    Meka VG, Gold HS, Cooke A, Venkataraman L, Eliopoulos GM, Moellering RC Jr, Jenkins SG.

    J Antimicrob Chemother. 2004 Oct;54(4):818-20. Epub 2004 Sep 3.PMID: 15347637 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Effects of glucose on fsr-mediated biofilm formation in Enterococcus faecalis.

    Pillai SK, Sakoulas G, Eliopoulos GM, Moellering RC Jr, Murray BE, Inouye RT.

    J Infect Dis. 2004 Sep 1;190(5):967-70. Epub 2004 Jul 27.PMID: 15295702 [PubMed - indexed for MEDLINE]Related articles

    39.

    Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.

    Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC Jr.

    Clin Infect Dis. 2004 Jun 15;38(12):1700-5. Epub 2004 May 21.PMID: 15227615 [PubMed - indexed for MEDLINE]Related articles

    40.

    Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

    Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L, DeGirolami PC, Eliopoulos GM, Moellering RC Jr, Gold HS.

    J Infect Dis. 2004 Jul 15;190(2):311-7. Epub 2004 Jun 9.PMID: 15216466 [PubMed - indexed for MEDLINE]Related articles

    41.

    Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.

    Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM.

    J Clin Microbiol. 2004 Jun;42(6):2398-402.PMID: 15184410 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    The continuing challenge of lower respiratory tract infections.

    Moellering RC Jr.

    Clin Infect Dis. 2004 May 15;38 Suppl 4:S319-21. No abstract available. PMID: 15127364 [PubMed - indexed for MEDLINE]Related articles

    43.

    Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.

    Sakoulas G, Gold HS, Venkataraman L, Moellering RC Jr, Ferraro MJ, Eliopoulos GM.

    J Antimicrob Chemother. 2003 Apr;51(4):1039-41. No abstract available. PMID: 12728937 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    New approaches to developing antimicrobials for resistant bacteria.

    Moellering RC Jr.

    J Infect Chemother. 2003 Mar;9(1):8-11. Review. No abstract available. PMID: 12673399 [PubMed - indexed for MEDLINE]Related articles

    45.

    Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?

    Sakoulas G, Eliopoulos GM, Moellering RC Jr, Novick RP, Venkataraman L, Wennersten C, DeGirolami PC, Schwaber MJ, Gold HS.

    J Infect Dis. 2003 Mar 15;187(6):929-38. Epub 2003 Mar 6.PMID: 12660939 [PubMed - indexed for MEDLINE]Related articles

    46.

    Linezolid: the first oxazolidinone antimicrobial.

    Moellering RC.

    Ann Intern Med. 2003 Jan 21;138(2):135-42. Review.PMID: 12529096 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Microbial resistance: bacteria and more.

    Wood MJ, Moellering RC Jr.

    Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S2-3. No abstract available. PMID: 12516024 [PubMed - indexed for MEDLINE]Related articles

    48.

    Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.

    Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC Jr, Ferraro MJ, Gold HS.

    J Infect Dis. 2002 Dec 1;186(11):1603-7. Epub 2002 Nov 4.PMID: 12447736 [PubMed - indexed for MEDLINE]Related articles

    49.

    Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae.

    Moellering RC Jr, Craig W, Edmond M, Farrell DJ, Ferraro MJ, File TM Jr, Klein J, Lonks J, Metlay JP, Sahm D, Talbot GH; Consensus Working Group.

    J Chemother. 2002 Jul;14 Suppl 3:42-56. Review.PMID: 12418560 [PubMed - indexed for MEDLINE]Related articles

    50.

    In vitro activity of the new oxazolidinone AZD2563 against Enterococci.

    Eliopoulos GM, Wennersten CB, Moellering RC Jr.

    Antimicrob Agents Chemother. 2002 Oct;46(10):3273-5.PMID: 12234858 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...